Compare Davita Inc (DVA) vs Global X Robo Global Robotics & Automation ETF (ROBO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs Global X Robo Global Robotics & Automation ETF — how do they compare? Davita Inc trades at $178.34 (market cap $11.72B), while Global X Robo Global Robotics & Automation ETF trades at $83.69. The key difference: Global X Robo Global Robotics & Automation ETF is trading nearer its 52-week high, Davita Inc nearer its low. Which is the better fit depends on your goals.
| DVA | ROBO | |
|---|---|---|
Market Cap | $11.72B | — |
Sector | Health | Sector/Thematic |
52-Week High | $240.96 | $90.34 |
52-Week Low | $103.87 | $62.34 |
Enterprise Value | $24.44B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $183.77, up 1.72% today, with a mixed technical picture showing bearish moving averages but bullish oscillators. The company reported strong Q2 2026 earnings of $4.02 per share, beating estimates, driven by volume growth. Revenue reached $13.64 billion in 2025, with a net income margin of 6.05%. Analyst consensus is a Buy with a $232.25 price target, though technical signals are bearish overall.
The outlook for DVA is cautiously optimistic, supported by earnings beats and volume growth, but risks include reimbursement pressure and high debt levels. The stock offers potential upside to the consensus target, yet investors face headwinds from margin compression and technical bearishness.
ROBO trades at $84.44, up 1.65% with bullish momentum from moving averages and a neutral oscillator stance. Recent news highlights robotics sector strength, with thematic ETFs gaining attention for AI infrastructure exposure. The stock faces resistance near $85, with support at $84.
Outlook remains positive due to AI-driven demand, but overbought RSI signals caution. Risks include cyclical exposure and valuation concerns. Analysts favor long-term growth, yet near-term volatility may test recent gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About Global X Robo Global Robotics & Automation ETF
ROBO is a thematic ETF that tracks the global robotics and automation industry. It provides diversified exposure to companies leading in industrial robotics, 3D printing, and surgical systems, with holdings like Intuitive Surgical and Zebra Technologies.
Read more on ROBO →
